Multiparametric Characterization of Colorectal Cancers (METRAD)
NCT07000474 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2025-06-03
Summary
The primary goal of this observational study is to assess the predictive value of a model developed through a multiparametric analysis of clinical images, histopathological data, CT scans, and molecular analysis. This analysis will be conducted on a retrospective cohort recruited at CHU Brest (training group). The model will then be validated using external cohorts from other centers (test group).
Conditions
- Colo-rectal Cancer
Interventions
- OTHER
-
Omics
Multiparametric analysis of clinical images, histopathological images, CT scans, and molecular analysis.
Sponsors & Collaborators
-
University Hospital, Brest
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-03-01
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- France
Study Locations
More Related Trials
-
Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer
NCT00551421 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study and Modulation of Immune Responses in Primary and Metastatic Colon Cancers
NCT06435689 ·Status: NOT_YET_RECRUITING
-
Mechanistic and Molecular Study of the Process of Metastatic Dissemination in Colorectal Cancer
NCT03613194 ·Status: UNKNOWN ·Phase: NA
-
A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer
NCT06637462 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Treatment PERSOnalization Based on Its Therapeutic Monitoring in Patients With Metastatic Colorectal Cancer Treated With REgorafenib
NCT04874207 ·Status: COMPLETED ·Phase: PHASE4
-
Genotyping of Metastatic Colorectal Cancer Patients for Precision Medicine Clinical Trials
NCT03350412 ·Status: UNKNOWN
-
Validation Study of Linear Quantification of CD3+ Cells in Localized Colorectal Carcinomas
NCT02364024 ·Status: COMPLETED
-
Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer
NCT00975897 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of Target-Guided Chemotherapy in Metastatic Colorectal Patients
NCT01453257 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Using the Oncogramme® Device to Select the First Line of Treatment for Patients With Metastatic Colorectal Cancer
NCT05299840 ·Status: RECRUITING ·Phase: NA
-
Multicenter Phase 2 Trial: a Tailored Strategy for Locally Advanced Rectal Carcinoma
NCT01333709 ·Status: COMPLETED ·Phase: PHASE2
-
Incidence, Risk Factor, Treatment and Overall Survival of Locally Recurrent Rectal Cancer
NCT05475301 ·Status: COMPLETED
-
Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer
NCT05725200 ·Status: RECRUITING ·Phase: PHASE2
-
Pemetrexed Plus a Comparator Versus a Combination of 2 Comparators in First-Line Treatment of Colorectal Cancer
NCT00079872 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy and Maximal Tumor Debulking of Multi-organ Colorectal Cancer Metastases
NCT01792934 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study of Biomarkers in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer
NCT00559676 ·Status: COMPLETED ·Phase: PHASE4
-
Chemotherapy and/or Metastasectomy in Treating Patients With Metastatic Colorectal Adenocarcinoma With Lung Metastases
NCT03599752 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
ARQ 197 in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer
NCT01075048 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Low Dose Metronomic Poly-chemotherapy for Metastatic CRC
NCT02280694 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Study of Irinotecan,Oxaliplatin Plus TS-1 in Untreated Metastatic Colorectal Cancer
NCT00506571 ·Status: UNKNOWN ·Phase: PHASE2
-
Nitazoxanide in Patients With Metastatic Colorectal Cancer
NCT06049901 ·Status: RECRUITING ·Phase: PHASE3
-
Detection of KRAS, NRAS et BRAF Mutations in Plasma Circulating DNA From Patients With Metastatic Colorectal Cancer
NCT02751177 ·Status: COMPLETED ·Phase: NA
-
A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer
NCT00478634 ·Status: COMPLETED ·Phase: PHASE1
-
Rechallenge of Cetuximab Combined With Irinotecan as Third-line Chemotherapy in Patients With Metastatic Colorectal Cancer - Phase II Study
NCT02316496 ·Status: TERMINATED ·Phase: PHASE2
-
Irinotecan Liposomes Combined with Cetuximab + Vermofenib in First-line Failure of Advanced Colorectal Cancer
NCT06763029 ·Status: RECRUITING ·Phase: PHASE2